Phase 1 Gene Therapy Trial In Patients With Advanced Heart Failure Using A Novel Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

被引：0

作者：

Henry, Timothy D., II ^{[1
]}

Chung, Eugene ^{[1
]}

Alvisi, Monica ^{[2
]}

Sethna, Ferzin ^{[3
]}

Murray, David E. ^{[4
]}

Traverse, Jay H. ^{[5
]}

Chen, Youjun ^{[3
]}

Webb, Stacy ^{[3
]}

Mittal, Monika ^{[3
]}

Ervin, Leigh ^{[6
]}

Walker, Kaitlyn ^{[6
]}

Sadek, Hesham A. ^{[7
]}

Mikhail, Sheila ^{[8
]}

Haghighi, Kobra ^{[9
]}

Jiang, Canwen ^{[8
]}

Samulski, Richard J. ^{[8
]}

Kranias, Evangelia L. ^{[10
]}

Tretiakova, Anna ^{[11
]}

Hajjar, Roger J. ^{[12
]}

机构：

[1] Christ Hosp, Cardiol, Cincinnati, OH 45219 USA

[2] ASKBIO, CHF, Berlin, Germany

[3] ASKBIO, Rsch & Dev, Rsch Triangle Pk, NC USA

[4] Univ Wisconsin, Cardiol, Madison, WI USA

[5] Allina Hlth Minneapolis Heart Inst, Cardiol, Minneapolis, MN USA

[6] ASKBIO, Clin Operat, Rsch Triangle Pk, NC USA

[7] Hesham Sadek, Cardiol, Irving, TX USA

[8] ASKBIO, Rsch Triangle Pk, NC USA

[9] Univ Cincinnati, Cardiol, Cincinnati, OH USA

[10] Univ Cincinnati, Coll Med, Pharmacol, Cincinnati, OH 45221 USA

[11] ASKBIO, Rsch, Rsch Triangle Pk, NC USA

[12] Massachusetts Gen Brigham, Gene & Cell Therapy Inst, Cambridge, MA USA

来源：

CIRCULATION | 2023年 / 148卷 / 25期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

23484

引用

页码：E301 / E302

页数：2

共 50 条

[1] Safety and efficacy of a phase 1 clinical gene therapy trial in patients with advanced heart failure using a rationally designed cardiotropic AAV vector targeting protein phosphatase inhibitor-1
Henry, T. D.
Chung, E.
Alvisi, M.
Sethna, F.
Murray, D.
Traverse, J. H.
Roberts, L.
Roessig, L.
Ervin, L.
Mikhail, S.
Jiang, C.
Samulski, J.
Kranias, E. G.
Tretiakova, A.
Hajjar, R. J.
EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 237 - 238
[2] Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart Failure
Watanabe, Shin
Ishikawa, Kiyotake
Fish, Kenneth
Oh, Jae Gyun
Motloch, Lukas J.
Kohlbrenner, Erik
Lee, Philyoung
Xie, Chaoqin
Lee, Ahyoung
Liang, Lifan
Kho, Changwon
Leonardson, Lauren
McIntyre, Maritza
Wilson, Scott
Samulski, R. Jude
Kranias, Evangelia G.
Weber, Thomas
Akar, Fadi G.
Hajjar, Roger J.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (14) : 1744 - 1756
[3] A first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel rationally designed cardiotropic adeno-associated vector
Alvisi, Monica
Henry, Timothy
Chung, Eugene
Traverse, Jay
Ervin, Leigh
Krupa, Shiva
Sadek, Hesham
Jiang, Canwen
Mikhail, Sheila
Haghighi, Kobra
Kranias, Evangelia
Samulski, Jude
Tretalova, Anna
Hajjar, Roger
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 173 : S113 - S113
[4] A first-in- human phase 1 clinical gene therapy trial for the treatment of non-ischemic heart failure using a novel rationally designed cardiotropic adeno-associated vector targeting calcium cycling
Alvisi, M.
Henry, T.
Chung, E.
Traverse, J.
Reynolds, K.
Ervin, L.
Krupa, S.
O'Callaghan, M.
Sadek, H.
High, K.
Jiang, C.
Mikhail, S.
Haghighi, K.
Tretiakova, A.
Samulski, R. J.
Kranias, E. G.
Hajjar, R. J.
HUMAN GENE THERAPY, 2022, 33 (23-24) : A203 - A203
[5] Rationally designed cardiotropic AAV2i8.I-1c demonstrates targeted cardiomyocyte distribution and a promising safety and efficacy profile in an ongoing phase 1 clinical gene therapy trial in patients with advanced heart failure
Alvisi, M.
Sethna, F.
Henry, T.
Chung, E.
Traverse, J.
Chen, Y.
Ozkan, T.
Webb, S.
Miittal, M.
Ervin, L.
Sadek, H.
Mikhail, S.
Haghighi, K.
Samulski, R. J.
Kranias, E. G.
Tretiakova, A.
Hajjar, R. J.
HUMAN GENE THERAPY, 2024, 35 (3-4) : A53 - A53
[6] Heart Failure-Inducible Gene Therapy Targeting Protein Phosphatase 1 Prevents Progressive Left Ventricular Remodeling
Miyazaki, Yosuke
Ikeda, Yasuhiro
Shiraishi, Kozo
Fujimoto, Shizuka N.
Aoyama, Hidekazu
Yoshimura, Koichi
Inui, Makoto
Hoshijima, Masahiko
Kasahara, Hideko
Aoki, Hiroki
Matsuzaki, Masunori
PLOS ONE, 2012, 7 (04):
[7] The Human G147D-Protein Phosphatase 1 Inhibitor-1 Polymorphism Is Not Associated with Altered Clinical Characteristics in Heart Failure
Chen, Guoli
Zhou, Xiaoyang
Pathak, Anand
Dorn, Gerald W., II
Kranias, Evangelia G.
CARDIOLOGY, 2009, 112 (03) : 224 - 231
[8] Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
Bowles, Dawn E.
McPhee, Scott W. J.
Li, Chengwen
Gray, Steven J.
Samulski, Jade J.
Camp, Angelique S.
Li, Juan
Wang, Bing
Monahan, Paul E.
Rabinowitz, Joseph E.
Grieger, Joshua C.
Govindasamy, Lakshmanan
Agbandje-McKenna, Mavis
Xiao, Xiao
Samulski, R. Jude
MOLECULAR THERAPY, 2012, 20 (02) : 443 - 455
[9] Reduced expression of protein phosphatase inhibitor-1 in human heart failure and functional consequences of its overexpression in cardiac myocytes
El-Armouche, A
Rau, T
Zimmermann, WH
Zolk, O
Harding, SE
Boknik, P
Eschenhagen, T
CIRCULATION, 2001, 104 (17) : 1 - 1
[10] Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure
B Greenberg
J Butler
G M Felker
P Ponikowski
A A Voors
J M Pogoda
R Provost
J Guerrero
R J Hajjar
K M Zsebo
Gene Therapy, 2016, 23 : 313 - 319

← 1 2 3 4 5 →